Document is current
Any future updates will be listed below
-
Authors
Kaplonek, Paulina
Cizmeci, Deniz https://orcid.org/0000-0003-3231-7726
Kwatra, Gaurav
Izu, Alane
Lee, Jessica Shih-Lu
Bertera, Harry L. https://orcid.org/0000-0001-7431-6436
Fischinger, Stephanie https://orcid.org/0000-0003-2307-3379
Mann, Colin https://orcid.org/0000-0003-0949-2075
Amanat, Fatima
Wang, Wenjun
Koen, Anthonet L.
Fairlie, Lee
Cutland, Clare L. https://orcid.org/0000-0001-8250-8307
Ahmed, Khatija
Dheda, Keertan https://orcid.org/0000-0001-7709-5341
Barnabas, Shaun L.
Bhorat, Qasim Ebrahim
Briner, Carmen
Krammer, Florian https://orcid.org/0000-0003-4121-776X
Saphire, Erica Ollman https://orcid.org/0000-0002-1206-7451
Gilbert, Sarah C. https://orcid.org/0000-0002-6823-9750
Lambe, Teresa
Pollard, Andrew J. https://orcid.org/0000-0001-7361-719X
Nunes, Marta
Wuhrer, Manfred https://orcid.org/0000-0002-0814-4995
Lauffenburger, Douglas A.
Madhi, Shabir A. https://orcid.org/0000-0002-7629-0636
Alter, Galit https://orcid.org/0000-0002-7680-9215
- License Information
-
More Information
Article History
Received: 9 May 2022
Accepted: 12 April 2023
First Online: 15 June 2023
Competing interests
: G.A. is a founder/equity holder in Seromyx Systems Inc. and Leyden Labs. She has served as a scientific advisor for Sanofi Vaccines and has collaborative agreements with GSK, Merck, Abbvie, Sanofi, Medicago, BioNtech, Moderna, BMS, Novavax, SK Bioscience, Gilead and Sanaria. The remaining authors declare no conflicting interests.
